Spire Healthcare maintains guidance despite Omicron impact
Spire Healthcare Group
223.50p
16:45 20/12/24
-0.67%
-1.50p
Private hospital group Spire Healthcare maintained annual guidance despite disruption at the start of the year from the Covid Omicron variant.
FTSE 250
20,450.69
17:14 20/12/24
n/a
n/a
FTSE 350
4,463.29
17:14 20/12/24
n/a
n/a
FTSE All-Share
4,421.11
17:04 20/12/24
n/a
n/a
Health Care Equipment & Services
10,620.84
17:14 20/12/24
-0.67%
-71.28
“Notwithstanding the disruption in the first quarter due to the Omicron variant, we are satisfied with our performance in the first four months of 2022,” Spire said ahead of its annual shareholder meeting on Wednesday.
“Accordingly, whilst we are yet to enter our busiest trading period, we reiterate our outlook for the full year, as set out in our full-year 2021 results announcement.”